Residents queue up to receive the Sinovac vaccine in Hong Kong. Photo: Yik Yeung-man
Residents queue up to receive the Sinovac vaccine in Hong Kong. Photo: Yik Yeung-man

Coronavirus: Hong Kong experts back making BioNTech’s Omicron-specific vaccine alternative to fourth dose

  • Data proves efficacy of German-made vaccine against original strain of virus as well as Omicron subvariants BA.4 and BA.5, Professor David Hui says
  • Experts also agree to shorten minimum interval period between doses of BioNTech paediatric vaccine for some children aged six months to five years old

Residents queue up to receive the Sinovac vaccine in Hong Kong. Photo: Yik Yeung-man
Residents queue up to receive the Sinovac vaccine in Hong Kong. Photo: Yik Yeung-man
READ FULL ARTICLE